We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+16.3%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$36.7B
AUM Growth
+$4.73B
Cap. Flow
+$3.45B
Cap. Flow %
9.42%
Top 10 Hldgs %
15.54%
Holding
3,403
New
385
Increased
1,787
Reduced
944
Closed
189

Sector Composition

Rank Sector Weight
1 Healthcare 9.66%
2 Technology 9.09%
3 Financials 7.96%
4 Consumer Staples 7.25%
5 Industrials 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFX icon
2976
PhenixFIN
PFX
$90M
$103K ﹤0.01%
673
+50
+8% +$7.42K
GEN icon
2977
CALL
Gen Digital
GEN
$17.5B
$102K ﹤0.01%
16,400
-1,500
-8% -$34.1K
AERI
2978
CALL
DELISTED
Aerie Pharmaceuticals
AERI
$102K ﹤0.01%
+23,800
New +$525K
LGCY
2979
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$102K ﹤0.01%
75,361
+342
+0.5% +$551
JONE
2980
DELISTED
Jones Energy, Inc.
JONE
$102K ﹤0.01%
+1,551
New +$95.8K
PIM
2981
Franklin Master Intermediate Income Trust
PIM
$151M
$100K ﹤0.01%
22,711
+2,544
+13% +$11.3K
SYY icon
2982
CALL
Sysco
SYY
$40.3B
$100K ﹤0.01%
93,400
+8,200
+10% +$421K
WVVI icon
2983
Willamette Valley Vineyards
WVVI
$11.9M
$100K ﹤0.01%
12,475
S
2984
DELISTED
Sprint Corporation
S
$99K ﹤0.01%
14,996
-3,508
-19% -$20.8K
VHC icon
2985
VirnetX Holding Corp
VHC
$63.1M
$98K ﹤0.01%
+1,608
New +$101K
TLPH icon
2986
Talphera
TLPH
$74.2M
$97K ﹤0.01%
+1,250
New +$83.1K
BIOA
2987
DELISTED
BioAmber Inc.
BIOA
$97K ﹤0.01%
22,950
+1,500
+7% +$5.54K
AVP
2988
DELISTED
Avon Products, Inc.
AVP
$96K ﹤0.01%
16,946
-5,583
-25% -$27.9K
LNG icon
2989
CALL
Cheniere Energy
LNG
$52.9B
$95K ﹤0.01%
62,700
+100
+0.2% +$4.22K
UNG icon
2990
United States Natural Gas Fund
UNG
$478M
$95K ﹤0.01%
708
-6
-0.8% -$792
TRR
2991
DELISTED
Trc Companies
TRR
$95K ﹤0.01%
+11,000
New +$79.6K
SGF
2992
DELISTED
Aberdeen Singapore Fund
SGF
$95K ﹤0.01%
+10,171
New +$94.4K
AMSC icon
2993
American Superconductor
AMSC
$1.59B
$94K ﹤0.01%
13,480
+1,280
+10% +$9.93K
NG icon
2994
NovaGold Resources
NG
$3.33B
$94K ﹤0.01%
16,815
-20,292
-55% -$126K
BX icon
2995
PUT
Blackstone
BX
$110B
$91K ﹤0.01%
+22,000
New +$581K
CLNE icon
2996
Clean Energy Fuels
CLNE
$346M
$91K ﹤0.01%
20,354
+275
+1% +$1.05K
IMUX icon
2997
Immunic
IMUX
$195M
$90K ﹤0.01%
37
KRO icon
2998
KRONOS Worldwide
KRO
$989M
$90K ﹤0.01%
10,850
-38,600
-78% -$273K
VOC icon
2999
VOC Energy
VOC
$51.9M
$90K ﹤0.01%
+30,223
New +$93.6K
OIL
3000
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
$90K ﹤0.01%
15,392
-29,500
-66% -$166K

Similar funds

Raymond James & Associates's Q3 2016 Portfolio in Review

As of Q3 2016, Raymond James & Associates held 3,403 positions worth $36.7B, up 15% from $31.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $3.45B of net new capital in Q3 2016, opening 385 new positions and adding to 1,787 existing holdings. Its largest new stake was iShares MSCI India Small-Cap ETF: 414,364 shares worth $15.2M.

By sector, the portfolio is most concentrated in Healthcare at 9.7% of assets, up from 9.6% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was TotalEnergies, an estimated $614M trimmed.

  • Raymond James & Associates's largest Q3 2016 buy was iShares MSCI India Small-Cap ETF: 414,364 shares worth $15.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2016, an estimated $196M increase.
  • Raymond James & Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $614M.
  • Raymond James & Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $61.1M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $36.7B portfolio in Q3 2016.
  • Raymond James & Associates opened 385 new positions and closed 189 in Q3 2016.
  • Raymond James & Associates's portfolio value rose 15% quarter-over-quarter to $36.7B.

Based on Raymond James & Associates's 13F filing for Q3 2016, filed 14 Nov 2016.